TGTX FY 2018 Earnings — TG Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

TGTXTG Therapeutics, Inc.

$5B

FY 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$152,000-0.3% YoY

Gross Profit

$64,00042.1% margin

Operating Income

-$174M-114736.8% margin

Net Income

-$173M-114132.9% margin

EPS (Diluted)

$-2.30

Cash Flow

Operating Cash Flow

-$129M

Free Cash Flow

-$129M

Stock-Based Comp.

$13M

Balance Sheet

Total Assets

$84M

Total Liabilities

$60M

Stockholders' Equity

$24M

Cash & Equivalents

$42M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$152,000	$152,381	-0.3%
Gross Profit	$64,000	$70,026	-8.6%
Operating Income	-$174M	-$119M	-46.9%
Net Income	-$173M	-$118M	-46.4%